SEC Comment Letter for Pulmonx (LUNG) — Nov 9, 2022
Pulmonx Corp
Date: Nov. 9, 2022 · CIK: 0001127537 · Accession: 0000000000-22-012240
AI Filing Summary & Sentiment
File numbers found in text: 333-268130
Letter
United States securities and exchange commission logo November 9, 2022 Glendon E. French President and Chief Executive Officer Pulmonx Corporation 700 Chesapeake Drive Redwood City, CA 94063 Re:Pulmonx Corporation Registration Statement on Form S-3 Filed November 3, 2022 File No. 333-268130 Dear Glendon E. French: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Benjamin Richie at 202-551-7857 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Mark Weeks
Show Raw Text
United States securities and exchange commission logo
November 9, 2022
Glendon E. French
President and Chief Executive Officer
Pulmonx Corporation
700 Chesapeake Drive
Redwood City, CA 94063
Re:Pulmonx Corporation
Registration Statement on Form S-3
Filed November 3, 2022
File No. 333-268130
Dear Glendon E. French:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Benjamin Richie at 202-551-7857 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Mark Weeks